Russia Unveils Groundbreaking Personalized mRNA Cancer Vaccine for 2025 Launch
Russia has developed a personalized mRNA cancer vaccine, EnteroMix, which it plans to begin administering to patients in October 2025. The vaccine utilizes technology similar to that of COVID-19 mRNA…